Nuvectis Pharma, Inc. Common Stock (NASDAQ: NVCT) last traded at $23.56, up 0.90% on the session. The quote above updates while this page is open; the figures below are drawn from Nuvectis Pharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
Nuvectis Pharma, Inc. Common Stock trades on NASDAQ under the ticker NVCT. Its market capitalisation is $767.62 million.
Valuation measures for Nuvectis Pharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $767.62M |
|---|---|
| Enterprise value | $758.75M |
| Price / book | 84.52 |
| Beta | 0.93 |
Trailing-twelve-month figures tagged in Nuvectis Pharma, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$27.85M |
|---|---|
| Return on equity | -306.61% |
| Cash | $22.16M |
Range and volume for NVCT over the past 52 weeks.
| 52-week high | $29.28 |
|---|---|
| 52-week low | $5.55 |
| Volume | 195.4K |
| Average volume | 312.4K |
| Previous close | $23.35 |
Dividend history for Nuvectis Pharma, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.